Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.

Holm, Neal T; Byrnes, Kerry; Li, Benjamin D L; Turnage, Richard H; Abreo, Fleurette; Mathis, James M; Chu, Quyen D

Holm, Neal T; Byrnes, Kerry; Li, Benjamin D L; Turnage, Richard H; Abreo, Fleurette; Mathis, James M; Chu, Quyen D.

Affiliation

Holm NT; Department of Surgery, Louisiana State University Health Sciences Center in Shreveport, Shreveport, Louisiana, USA.

J Surg Res ; 141(1): 53-9, 2007 Jul.

Article in En | MEDLINE | ID: mdl-17574038

Subject(s)

Breast Neoplasms/metabolism; Neoplasm Recurrence, Local/diagnosis; Receptor, ErbB-2/metabolism; Receptors, CXCR4/metabolism; Breast Neoplasms/genetics; Breast Neoplasms/pathology; Disease Progression; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasm Recurrence, Local/etiology; Neoplasm Recurrence, Local/metabolism; Predictive Value of Tests; Prognosis; Prospective Studies; Receptor, ErbB-2/genetics; Receptors, CXCR4/genetics; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Receptors, CXCR4 / Neoplasm Recurrence, Local Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: J Surg Res Year: 2007 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links